These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8318645)

  • 1. Hyperplasia and breast cancer.
    Bright RA
    Cancer Causes Control; 1993 May; 4(3):289. PubMed ID: 8318645
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessing risk models for atypical hyperplasia: age may not matter.
    Mazzola E; Coopey SB; Griffin M; Polubriaginof F; Buckley JM; Parmigiani G; Garber JE; Smith BL; Gadd MA; Specht MC; Guidi A; Hughes KS
    Breast Cancer Res Treat; 2017 Sep; 165(2):285-291. PubMed ID: 28589368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women.
    Bhathal PS; Brown RW; Lesueur GC; Russell IS
    Br J Cancer; 1985 Feb; 51(2):271-8. PubMed ID: 3966983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of benign and preinvasive breast diseases.
    Altaf FJ; Abdullah LS; Jamal AA
    Saudi Med J; 2004 Apr; 25(4):493-7. PubMed ID: 15083223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women.
    Nielsen M; Jensen J; Andersen J
    Cancer; 1984 Aug; 54(4):612-5. PubMed ID: 6744199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign breast diseases: risk factor or precancerous state?
    Gerber M
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():113-8. PubMed ID: 8298440
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical staining patterns of benign breast biopsies by 323/A3 and Ca1 monoclonal antibodies related to epidemiological and radiological risk criteria.
    Courtney SP; Williams S; Mansel RE
    Int Surg; 1992; 77(1):55-9. PubMed ID: 1374368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk lesions in high-risk women: a high-risk formalin-based biology!
    Adem C; Jenkins RB; Capron F; Stoppa-Lyonnet D
    J Clin Oncol; 2004 Mar; 22(6):1159-61; author reply 1161-2. PubMed ID: 15020622
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology of precancerous conditions and breast cancer].
    Zhivetskiĭ AV
    Vrach Delo; 1973 Nov; 11():61-4. PubMed ID: 4786935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessing breast cancer risk in women with mammary hyperplasia of different syndromes using mammography].
    Hu SF; Chen HF; Rong QW
    Zhong Xi Yi Jie He Xue Bao; 2007 Mar; 5(2):195-7. PubMed ID: 17352880
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathology of "precancerous" breast disease.
    Walker RA
    Pathol Annu; 1994; 29 ( Pt 2)():75-97. PubMed ID: 7936752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 15. Cohort study of women affected by gross cystic disease. Correlation between cationic and hormonal composition of breast cyst fluid and the risk of breast cancer.
    Naldoni C; Bruzzi P; Bucchi L; Gordini S; Torta M; Caraci P; Orlandi F
    Ann N Y Acad Sci; 1990; 586():272-5. PubMed ID: 2357007
    [No Abstract]   [Full Text] [Related]  

  • 16. Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.
    Said SM; Visscher DW; Nassar A; Frank RD; Vierkant RA; Frost MH; Ghosh K; Radisky DC; Hartmann LC; Degnim AC
    Cancer; 2015 May; 121(10):1548-55. PubMed ID: 25639678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of breast cancer. Progression from hyperplasia to neoplasia as predicted by angiogenesis.
    Gullino PM
    Cancer; 1977 Jun; 39(6 Suppl):2697-703. PubMed ID: 326375
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical epithelial hyperplasia of the breast: state of the art.
    Dion L; Racin A; Brousse S; Beltjens F; Cauchois A; Levêque J; Coutant C; Lavoué V
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):943-53. PubMed ID: 27367571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast disease and breast cancer risk: morphology and beyond.
    Schnitt SJ
    Am J Surg Pathol; 2003 Jun; 27(6):836-41. PubMed ID: 12766590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.